The second digital therapeutic device for improving insomnia in Korea, 'WELT-I,' developed by WELT

[관련기사 = 국내 두 번째 디지털치료기기도 불면증 개선…웰트 'WELT-I'] The second digital therapeutic device for improving insomnia in Korea, 'WELT-I,' developed by WELT Based on the data entered by the patient, the device improves the patient's insomnia over a period of 6 weeks. The second digital therapeutic device (DTx) in South Korea is also dedicated to treating insomnia. The Ministry of Food and Drug Safety (MFDS) approved the manufacturing license for cognitive therapy software (product name: WELT-I) developed by

SK Bioscience announces "Investment of 2.4 trillion won over the next 5 years despite negative growth"

[관련 기사 = SK바이오사이언스 "향후 5년 집중 투자 시기…마이너스 성장에도 미래를 위한 길"] SK Bioscience announces "Investment of 2.4 trillion won over the next 5 years despite negative growth" Jae-yong Ahn, CEO of SK Bioscience, unveils plans to boost global competitiveness During a recent press conference, Jae-yong Ahn, SK Bioscience CEO expressed “He determine to pursue concentrated investments over the next five years to secure global competitiveness, despite the rapid changes in business environment due to the endemic.” SK B

Daewoong Pharmaceutical Launches Envlo, Its First Domestic SGLT-2 Inhibitor Medication.

Domestic new drug No. 36 has demonstrated superior blood sugar lowering effects and safety with a low dosage of 0.3mg. [관련기사 = 대웅제약, 국내 첫 SGLT-2 억제제 신약 '엔블로정' 출시 동시에 보험급여 적용] Daewoong Pharmaceutical has succeeded in localizing a SGLT-2 inhibitor drug for the treatment of diabetes, becoming the first domestic pharmaceutical company to do so. The company announced on May 1 that its new drug, Envlo, has been approved for insurance coverage and will be officially launched in Korea. Envlo is available in a 0.3mg dose (ingredient name: enavogliflozin) and has been approved for three indications: monotherapy, combinati

Where have the medical doctors gone in the last 10 years? The medical practitioner is on the rise by 13,000.

Getty Images [관련기사=10년간 의사들 어디로 갔나 봤더니…개원의사 '1만3000명' 증가] Patients are flocking to the big hospitals, while doctors are soaring to clinic-level medical institutions. The number of doctors in hospitals and convalescent hospitals is on the decline. The medical treatment-related organization that has been chosen by most medical doctors for the past ten years was a clinic-level medical institution. The number of medical doctors who work in clinic-level medical institutions has increased by 4.1%p ove

Sleep related to dementia and cardiocerebrovascular disease Adequate amount of sleep is essential for good health

[관련기사=세계 수면의 날 특별기획, 치매‧심뇌혈관 질환과도 관련된 '수면'…"건강에 꼭 필요한 수면" 강조] [Special Project] Hosted by the Korean Sleep Research Society & Korean Neurological Association 「Symposium on World Sleep Day 2023」 "Sleep has a great impact on the physical, mental, and cognitive functions for our body even if we miss it only one day. Sleep is linked to all the functions of our body from head to toe and we could sustain our healthy life with just a bit of effort." Prof. Ki-Young JUNG, president of Korean Sleep Resear

The launch of 1st digital therapeutic device AIMMED 'SOMZZ'

[관련기사 = "1호 디지털치료기기 에임메드 '솜즈' 이제부터 시작이다…이르면 6월 첫 처방·11월 의원급 판매"] "The launch of 1st digital therapeutic device AIMMED 'SOMZZ'... Expected to be prescribed starting in June and sold in clinics by November." [Interview] DTx division head of AIMMED, Jung Kyung-ho, "plans to focus on spin-off and IPO in the near future, commercialize one product per year... Collaborate with wearables and pharmaceutical companies." Starting from June of this year, insomnia patients can use the first domestically prod

Boryung is focused on 'space medicine'

[관련기사 = '우주의학'에 꽂힌 보령 "미지의 환경 '우주' 연구해 인류건강에 기여하겠다"] Boryung is focused on 'space medicine' and aims to contribute to human health by researching the “unknown environment of ‘space’." In response to a series of doubts raised by shareholders and industry insiders, Kim Jung-kyun, the third-generation CEO of Boryung, emphasized the reasons and importance of pursuing the space business in the annual shareholder meeting and annual letter. Boryung (formerly Boryung Pharmaceuticals has reiterated its c

The Nursing Act was approved to be submitted to the Assembly plenary session with 16 votes for approval out of 24 votes

[관련기사=2월 9일자 간호법, 24명 중 찬성 16표로 '본회의 직회부' 가결] The Nursing Act and Medical License Revocation Act, ect. were submitted to the Assembly plenary session So far, seven bills containing Nursing Act and Medical License Revocation Act, etc which have been pending in the Legislation and Judiciary Committee of the National Assembly were directly referred to the plenary session. The Health and Welfare Committee of the National Assembly held a general meeting on Feb. 9, and decided to submit the pending ag

Non-face-to-face treatment centered on clinic-level facilities for the returning patients

[관련기사=2월 9일 복지부-의협, 비대면 진료 의원급 중심•재진환자 대상 '합의'] The Ministry of Health & Welfare and the KMA agreed, non-face-to-face treatment centered on clinic-level facilities for the returning patients 2nd meeting of the ‘Consultative Body for Current Medical Issues’ on Feb. 9th Prohibition of the dedicated medical facilities for non-face-to-face treatment The government and the medical community have agreed to manage non-face-to-face medical treatment centered on returning patients at clinic-level medical

Emergency cardiovascular surgery became impossible in the Yeongdong region

Professor Jang-Whan Bae of Cardiology Department at Chungbuk National University Hospital. - Exempt from overnight duty for only over 60 years of age - Rapidly reducing of the cardiologists [관련기사=2023년 1월 16일 영동 지역 심혈관 응급시술 불가, 환갑 넘어야 당직 면제 ...씨 마르는 심장내과 의사들] It has been pointed out that measures are urgently needed since the number of specialists on coronary artery disease intervention are declining rapidly. The Korean Society of Interventional Cardiology has appealed to the government for supp